One-year clinical outcomes
| Hypertension | P value‡ | ||
| Enrolment | After 1 year | N=1075 | |
| Average blood pressure | 157/94 (SD†: systolic 28, diastolic 18) | 136*/83* (SD: systolic 21, diastolic 13) | Systolic: <0.0001 Diastolic: <0.0001 |
| Stage III hypertension BP >180/110 | 26.2% (n=322) | 4.7%* (n=50) | <0.0001 |
| Controlled hypertension BP <140/90 | 53.6% (n=575) | ||
| Asthma | P value‡ | ||
| Enrolment | After 1 year | N=331 | |
| Asthma severity: moderate or severe persistent | 21.8% (n=72) | 12.6%* (n=42) | 0.0007 |
| Epilepsy | P value‡ | ||
| Enrolment | After 1 year | N=207 | |
| Average number of seizures in the past 3 months | 2.4 | 1.5* | 0.0003 |
| Zero seizures since last visit | 38.2% (n=79) | ||
| Diabetes | P value‡ | ||
| Enrolment | After 1 year | N=52 | |
| Average fingerstick glucose§ | 230 (SD 155) | 179* (SD 90) | 0.0124 |
| Fingerstick glucose <200 | 73% (n=38) | ||
| Average blood pressure | 143/89 (SD: systolic 25, diastolic 14) | 130*/84* (SD: systolic 22, diastolic 11) | Systolic: <0.0001 Diastolic: <0.0001 |
| BP <140/90 | 69% (n=36) | ||
| HIV | P value‡ | ||
| After 1 year (N=2250) | |||
| Patients with a recorded viral load | 80% (n=1807) | ||
| Patients with a viral load <1000 | 94% (n=1692) | ||
| Patients with an undetectable viral load | 85% (n=1527) | ||
Greyed boxes indicate analysis that was not included as part of the study because these measurements were not relevant at the baseline clinic visit.
*Statistically significant at p<0.05 level.
†SD showed for all averages.
‡Paired one-sided t-test for normal continuous values, Wilcoxon signed rank test for non-normal continuous variables (number of seizures for patients with epilepsy) and McNemar’s Χ2 for proportions.
§Combines random, fasting and unlabelled.
BP, blood pressure.